Literature DB >> 23444185

The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans.

June Fabian1, Saraladevi Naicker, Stewart Goetsch, Willem Daniel Francois Venter.   

Abstract

BACKGROUND: Little is known about the progression of kidney disease in HIV-infected patients in developing countries in the era of antiretroviral therapy (ART).
METHODS: HIV-infected patients were screened for kidney disease. Kidney biopsies were performed before and after initiation of ART to assess the clinical and histological response to treatment. Data were collected from all participants in accordance with the study protocol. The mean follow-up was 2.4 patient years on ART.
RESULTS: There was a rapid immunological and renal response to ART. The renal response was reflected by a significant rise in the estimated glomerular filtration rate (eGFR) and rapid regression of proteinuria. The histological patterns were highly variable, ranging from non-specific lesions such as mesangial hyperplasia and interstitial nephritis to HIV-immune complex disease (HIV-ICD) with or without features of HIV-associated nephropathy (HIVAN). In the follow-up biopsies, the histological response to treatment was variable with a combination of no change, progression or regression of lesions.
CONCLUSIONS: This study demonstrated a spectrum of renal histological lesions in HIV-associated kidney disease. Initiation of ART produced a rapid and sustained clinical renal response in all participants, irrespective of the histology. Follow-up biopsies showed an inconsistent histological response of lesions to treatment. In lesions that regressed, there appeared to be a discrete lag in histological response when compared with the rapid clinical response.

Entities:  

Keywords:  HIV; HIV-associated nephropathy; antiretroviral therapy; renal histopathology

Mesh:

Year:  2013        PMID: 23444185     DOI: 10.1093/ndt/gft010

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

Review 1.  Viral-Associated GN: Hepatitis C and HIV.

Authors:  Warren L Kupin
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

2.  Clinicopathological correlation of kidney disease in HIV infection pre- and post-ART rollout.

Authors:  Nina Elisabeth Diana; Malcolm Davies; Pulane Mosiane; Alda Vermeulen; Saraladevi Naicker
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

3.  Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection.

Authors:  Murli U Purswani; Kunjal Patel; Cheryl A Winkler; Stephen A Spector; Rohan Hazra; George R Seage; Lynne Mofenson; Brad Karalius; Gwendolyn B Scott; Russell B Van Dyke; Jeffrey B Kopp
Journal:  J Acquir Immune Defic Syndr       Date:  2016-09-01       Impact factor: 3.731

4.  Risk factors and co-morbidities associated with changes in renal function among antiretroviral treatment-naïve adults in South Africa: A chart review.

Authors:  Shirelle Assaram; Tivani P Mashamba-Thompson; Nombulelo P Magula
Journal:  South Afr J HIV Med       Date:  2018-04-12       Impact factor: 2.744

5.  The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa.

Authors:  Nicola Wearne; Charles R Swanepoel; Maureen S Duffield; Bianca J Davidson; Kathryn Manning; Nicki Tiffin; Andrew Boulle; Brian L Rayner; Priyanka Naidu; Ikechi G Okpechi
Journal:  BMC Nephrol       Date:  2019-02-06       Impact factor: 2.388

6.  HIV-associated Immune Complex Kidney Disease with C3-dominant Deposition Induced by HIV Infection after Treatment of IgA Nephropathy.

Authors:  Chieko Kawakita; Masaru Kinomura; Nozomu Otaka; Masashi Kitagawa; Hitoshi Sugiyama; Nobuchika Kusano; Masashi Mizuno; Jun Wada
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

7.  Association of HIV Suppression With Kidney Disease Progression Among HIV-Positive African Americans With Biopsy-Proven Classic FSGS.

Authors:  Blaithin A McMahon; Mohamad Hanouneh; Alice Chedid; Derek M Fine; Teresa K Chen; Matthew Foy; Gregory M Lucas; Michelle M Estrella; Mohamed G Atta
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-15       Impact factor: 3.771

Review 8.  Pharmacotherapeutic options for kidney disease in HIV positive patients.

Authors:  Anam Tariq; Hannah Kim; Hashim Abbas; Gregory M Lucas; Mohamed G Atta
Journal:  Expert Opin Pharmacother       Date:  2020-09-21       Impact factor: 4.103

Review 9.  Update on current management of chronic kidney disease in patients with HIV infection.

Authors:  Nina E Diana; Saraladevi Naicker
Journal:  Int J Nephrol Renovasc Dis       Date:  2016-09-16

Review 10.  Renal manifestations of HIV during the antiretroviral era in South Africa: a systematic scoping review.

Authors:  Shirelle Assaram; Nombulelo P Magula; Suman Mewa Kinoo; Tivani P Mashamba-Thompson
Journal:  Syst Rev       Date:  2017-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.